
Amgen shares top $100 as fears fade over biosimilars
By Stephen Nellis / Friday, April 5th, 2013 / Comments Off on Amgen shares top $100 as fears fade over biosimilars
NEXT ARTICLE →
Up in the air: When it makes sense to take your small business into the cloud
← PREVIOUS ARTICLE
Green Coast 2013: How the region is leading the way in energy efficiency
Related Articles
Popular articles
Sponsored:
Staples Construction
Home of the Week
Sponsored ListingTreetop Oasis, Santa Barbara
Sponsored
McCarthy Companies
-